Gmail Calendar Documents Reader Web more »
Help | Sign in
Go to Google Groups Home
   
Discussions for Sinovac Biotech Ltd. View all discussions
My starred discussions
My profile

Message from discussion News
The group you are posting to is a Usenet group. Messages posted to this group will make your email address visible to anyone on the Internet.
Your reply message has not been sent.
Your post was successful
 
From:
To:
Cc:
Followup To:
Add Cc | Add Followup-to | Edit Subject
Subject:
Validation:
For verification purposes please type the characters you see in the picture below or the numbers you hear by clicking the accessibility icon. Listen and type the numbers you hear
 
oh buck market  
View profile  
 More options Nov 5 2009, 7:47 pm
From: oh buck market <yhst...@gmail.com>
Date: Thu, 5 Nov 2009 16:47:51 -0800 (PST)
Local: Thurs, Nov 5 2009 7:47 pm
Subject: Re: News
Forward | Print | View thread | Report this message | Find messages by this author
So far, nobody knows how much the Chinese Government will pay for the
vaccine, however, since it is prohibited to be exported by Government,
and if China government just wants to pay only half of the
international market price, that means that shareholder's interest in
SVA is sacrificed, if it is so, can shareholders in USA sue SVA or
China government?

On Nov 5, 7:32 pm, tickerwatch <aileenn...@gmail.com> wrote:

> The Chinese govt is paying around $3 per shot, and the calculation
> should be based on doses already delivered(not 65 million). I wonder
> if SVA is going to take the hit for the development cost of the drug
> upfront or accrue it till year-end.  That would certain have an impact
> on the profitability for the quarter.

> On Nov 6, 7:58 am, wittle <jinsant...@gmail.com> wrote:

> > So if Hong Kong is paying $10 a dose for 3 million doses and Sinovac
> > is supplying 65 million doses of h1n1 vaccine to the Chinese Gov.,
> > with tax credits, that equals 65 million x $10 and an unbelievable 650
> > million dollars. Their previous revenue guidance was revised up from
> > 60 million dollars to an "unknown" figure. The 60 million was
> > previously revised up from 22 million. On Q2 SVA's return on equity
> > was 17.7%. Reuters has projected an EPS of .07 cents for Q3. Q2's EPS
> > was .14. Is my belief an EPS of .49 for Q3 realistic? If someone comes
> > up with a more exact EPS guess, I'd like to see it. The unknown is how
> > many doses of h1n1 will SVA receive payment for in this quarter. I
> > believe a partial order payment was paid by the Chinese Gov. for the
> > 65 million doses ordered and the remaining (70%?) will be paid upon
> > delivery. So a ballpark guess is 50% of the revenue on 65 million
> > doses will be reported this quarter.

> > On Nov 5, 3:50 pm, David <david.dodd...@gmail.com> wrote:

> > > For your information...

> > >http://www.reuters.com/article/marketsNews/idCNSP7332220091105?rpc=44... quoted text -

> > - Show quoted text -- Hide quoted text -

> - Show quoted text -


    Forward  
You must Sign in before you can post messages.
To post a message you must first join this group.
Please update your nickname on the subscription settings page before posting.
You do not have the permission required to post.

Google Home - Terms of Service - Privacy Policy

©2010 Google